Three items of pandemic news you may have missed recently: Watching the virus evolve variants in a single human; a damning report on Emergent’s vaccine manufacturing plant; and the dimming prospects for herd immunity. Plus news briefs and a frippery. … Continue reading →
Herewith three items of pandemic news you may have missed recently: Two more Russian vaccines; a primer on T-cell immunity; and fabulous results from a real-world study of vaccine effectiveness. Plus news briefs and two fripperies. 90% effective in the … Continue reading →
Herewith three items of pandemic news you may have missed recently: Evidence that post-infection people could need only one shot; asymptomatics and long Covid; and AstraZeneca on pause across Europe over safety concerns. Plus news briefs and a frippery. AstraZeneca … Continue reading →
Herewith three items of pandemic news you may have missed recently: Youyang Gu’s model of the path to herd immunity; hesitancy from several directions about Johnson & Johnson’s vaccine; and the latest on pandemic passports. Plus news briefs and a … Continue reading →
Herewith three items of pandemic news you may have missed recently: A caution for those scheduling mammograms around the time of vaccination; sterilizing immunity from vaccines; and peptides for prevention and treatment. Plus news briefs and a frippery. Peptides Dr. … Continue reading →
